RATIONALE: Germline ablation of the cytoskeletal protein nonmuscle myosin II (NMII)-B results in embryonic lethality, with defects in both the brain and heart. Tissue-specific ablation of NMII-B by a Cre recombinase strategy should prevent embryonic lethality and permit study of the function of NMII-B in adult hearts. OBJECTIVE: We sought to understand the function of NMII-B in adult mouse hearts and to see whether the brain defects found in germline-ablated mice influence cardiac development. METHODS AND RESULTS: We used a loxP/Cre recombinase strategy to specifically ablate NMII-B in the brains or hearts of mice. Mice ablated for NMII-B in neural tissues die between postnatal day 12 and 22 without showing cardiac defects. Mice deficient in NMII-B only in cardiac myocytes (B(alphaMHC)/B(alphaMHC) mice) do not show brain defects. However, B(alphaMHC)/B(alphaMHC) mice display novel cardiac defects not seen in NMII-B germline-ablated mice. Most of the B(alphaMHC)/B(alphaMHC) mice are born with enlarged cardiac myocytes, some of which are multinucleated, reflecting a defect in cytokinesis. Between 6 to 10 months, they develop a cardiomyopathy that includes interstitial fibrosis and infiltration of the myocardium and pericardium with inflammatory cells. Four of 5 B(alphaMHC)/B(alphaMHC) hearts develop marked widening of intercalated discs. CONCLUSIONS: By avoiding the embryonic lethality found in germline-ablated mice, we were able to study the function of NMII-B in adult mice and show that absence of NMII-B in cardiac myocytes results in cardiomyopathy in the adult heart. We also define a role for NMII-B in maintaining the integrity of intercalated discs.
RATIONALE: Germline ablation of the cytoskeletal protein nonmuscle myosin II (NMII)-B results in embryonic lethality, with defects in both the brain and heart. Tissue-specific ablation of NMII-B by a Cre recombinase strategy should prevent embryonic lethality and permit study of the function of NMII-B in adult hearts. OBJECTIVE: We sought to understand the function of NMII-B in adult mouse hearts and to see whether the brain defects found in germline-ablated mice influence cardiac development. METHODS AND RESULTS: We used a loxP/Cre recombinase strategy to specifically ablate NMII-B in the brains or hearts of mice. Mice ablated for NMII-B in neural tissues die between postnatal day 12 and 22 without showing cardiac defects. Mice deficient in NMII-B only in cardiac myocytes (B(alphaMHC)/B(alphaMHC) mice) do not show brain defects. However, B(alphaMHC)/B(alphaMHC) mice display novel cardiac defects not seen in NMII-B germline-ablated mice. Most of the B(alphaMHC)/B(alphaMHC) mice are born with enlarged cardiac myocytes, some of which are multinucleated, reflecting a defect in cytokinesis. Between 6 to 10 months, they develop a cardiomyopathy that includes interstitial fibrosis and infiltration of the myocardium and pericardium with inflammatory cells. Four of 5 B(alphaMHC)/B(alphaMHC) hearts develop marked widening of intercalated discs. CONCLUSIONS: By avoiding the embryonic lethality found in germline-ablated mice, we were able to study the function of NMII-B in adult mice and show that absence of NMII-B in cardiac myocytes results in cardiomyopathy in the adult heart. We also define a role for NMII-B in maintaining the integrity of intercalated discs.
Authors: Igor Kostetskii; Jifen Li; Yanming Xiong; Rong Zhou; Victor A Ferrari; Vickas V Patel; Jeffery D Molkentin; Glenn L Radice Journal: Circ Res Date: 2005-01-20 Impact factor: 17.367
Authors: A N Tullio; D Accili; V J Ferrans; Z X Yu; K Takeda; A Grinberg; H Westphal; Y A Preston; R S Adelstein Journal: Proc Natl Acad Sci U S A Date: 1997-11-11 Impact factor: 11.205
Authors: Vinciane Gaussin; Tom Van de Putte; Yuji Mishina; Mark C Hanks; An Zwijsen; Danny Huylebroeck; Richard R Behringer; Michael D Schneider Journal: Proc Natl Acad Sci U S A Date: 2002-02-19 Impact factor: 11.205
Authors: David G McFadden; Ana C Barbosa; James A Richardson; Michael D Schneider; Deepak Srivastava; Eric N Olson Journal: Development Date: 2004-12-02 Impact factor: 6.868
Authors: Mary Anne Conti; Sharona Even-Ram; Chengyu Liu; Kenneth M Yamada; Robert S Adelstein Journal: J Biol Chem Date: 2004-08-02 Impact factor: 5.157
Authors: Andrew D Doyle; Matthew L Kutys; Mary Anne Conti; Kazue Matsumoto; Robert S Adelstein; Kenneth M Yamada Journal: J Cell Sci Date: 2012-02-10 Impact factor: 5.285
Authors: Emin D Ozkan; Massimiliano Aceti; Thomas K Creson; Camilo S Rojas; Christopher R Hubbs; Megan N McGuire; Priyanka P Kakad; Courtney A Miller; Gavin Rumbaugh Journal: J Neurochem Date: 2015-05-29 Impact factor: 5.372
Authors: Aidan M Fenix; Abigail C Neininger; Nilay Taneja; Karren Hyde; Mike R Visetsouk; Ryan J Garde; Baohong Liu; Benjamin R Nixon; Annabelle E Manalo; Jason R Becker; Scott W Crawley; David M Bader; Matthew J Tyska; Qi Liu; Jennifer H Gutzman; Dylan T Burnette Journal: Elife Date: 2018-12-12 Impact factor: 8.140